Status:

WITHDRAWN

Surgical Approach for Primary Hyperparathyroidism in the Elderly

Lead Sponsor:

Rambam Health Care Campus

Conditions:

Multigland Disease in Primary Hyperparathyroidism

Eligibility:

All Genders

65+ years

Phase:

NA

Brief Summary

Following a personal observation and a retrospective analysis of the data, the investigators hypothesise that there is increased frequency of multiple gland disease in primary hyperparathyroidism in t...

Eligibility Criteria

Inclusion

  • patient with primary hyperparathyroidism.
  • patients with an indication for surgery.
  • Suspected adenoma on preop images.
  • minimum age of 65.

Exclusion

  • patients younger than 65.
  • cases where imaging didn't locate any adenoma.
  • patients who did not consent to participate in the study.

Key Trial Info

Start Date :

December 1 2011

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

November 1 2015

Estimated Enrollment :

Patients enrolled

Trial Details

Trial ID

NCT01484379

Start Date

December 1 2011

End Date

November 1 2015

Last Update

August 25 2017

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Rambam Health Care Campus

Haifa, Israel